Contact: Mike Frick, mike.frick@treatmentactiongroup.org It's a privilege to provide a perspective from civil society at this strategic convening of the TB Vaccine Accelerator Council. The five recommendations coming out of the recent Accelerator Forum make clear just how complex this…
Contact: Mike Frick, TB project co-director, mike.frick@treatmentactiongroup.org November 6 2025, New York — Treatment Action Group (TAG) welcomes the report published today by the World Health Organization TB Vaccine Accelerator Council on how to finance global, equitable access to new…
CONTACT: Mike Frick, mike.frick@treatmentactiongroup.org Well-conducted study sponsored by Indian Council of Medical Research did not meet primary efficacy endpoint of preventing microbiologically confirmed TB disease April 15, 2026 — Treatment Action Group (TAG) acknowledges the long-awaited publication of results from…